Live Breaking News & Updates on Pimera Therapeutics

Stay updated with breaking news from Pimera therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pimera Therapeutics Announces Oral Presentation on PMR-116 at the American Association for Cancer Research (AACR) Annual Meeting 2022

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases. ....

United States , Amy Conrad , Orleans Convention Center , American Association For Cancer Research , Pimera Therapeutics Inc , Pimera Therapeutics , American Association , Cancer Research , Annual Meeting , New Orleans , Great Hall , New Orleans Convention , Investor Contact ,

Pimera Therapeutics Announces Oral Presentation on PMR-116 at the American Association for Cancer Research (AACR) Annual Meeting 2022

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases. ....

United States , Amy Conrad , Orleans Convention Center , American Association For Cancer Research , Pimera Therapeutics Inc , Pimera Therapeutics , American Association , Cancer Research , Annual Meeting , New Orleans , Great Hall , New Orleans Convention , Investor Contact ,

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases. ....

Mustapha Haddach , Amy Conrad , Luc Furic , Ross Hannan , Australian National University , Department Of Defense , Dean Research Biomedical , Cancer Research , Prostate Cancer Research Program , Department Of Cancer Biology , Pimera Therapeutics Inc , Pimera Therapeutics , Translational Prostate Cancer Research , Peter Maccallum Cancer Centre , Professor Ross Hannan , Centenary Chair , Cancer Biology , Associate Dean Research , Peter Maccallum Cancer , Medical Research Acquisition , Award Number , Investor Contact ,

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases. ....

Mustapha Haddach , Amy Conrad , Luc Furic , Ross Hannan , Australian National University , Department Of Defense , Dean Research Biomedical , Cancer Research , Prostate Cancer Research Program , Department Of Cancer Biology , Pimera Therapeutics Inc , Pimera Therapeutics , Translational Prostate Cancer Research , Peter Maccallum Cancer Centre , Professor Ross Hannan , Centenary Chair , Cancer Biology , Associate Dean Research , Peter Maccallum Cancer , Medical Research Acquisition , Award Number , Investor Contact ,